Latest news

Saturday was our distributors’ training meeting, and it was great to have our team of distributors from Italy, Switzerland, the UK, and Portugal in Basel.

Read more about our recent article published by Prime News: The future of hand surgery begins in Muttenz
From head physician to entrepreneur: instead of retiring, Belgian Frédéric Schuind wants to revolutionize hand surgery.

In collaboration with swisspeers and BLKB, our team had the chance to present Spirecut’s journey from Swiss Start-up to International MedTech Player in 2023.

Spirecut is pleased to announce the publication of our research results in the Journal Of Ultrasound.

Spirecut at the 28th Brussels Hand / Upper Limb Symposium 2024

The proceeds from our financing round with private investors provides additional resources to fast-track our plans.

This registration allows for using the “Spirecut®” and “Sono-Instruments®” designations in the United States. It encompasses all goods and services in classes 10 (Medical devices), 41 (Education and training services), 42 (Scientific and technological services), and 44 (Medical services).

We’re pleased to announce Spirecut’s market launch in Italy in partnership with Bimar Ortho.

On February 6, 2024, Agefi published an insightful article by Sophie Marenne, highlighting our strides in revolutionizing hand surgery.

Spirecut’s team recently attended the Hand Val d’Isère course in the French Alps.

At the beginning of 2023, Spirecut moved from Fribourg to Muttenz. The last three years have seen a steep development curve and several awards. The ‘100 fürs Baselbiet’ initiative, which means ‘100 for the Basel region’, is a cornerstone of this success story.

On February 4th, 2023, we led a training at Université Libre de Bruxelles for British and Belgian hand surgeons, MSK radiologists and sports doctors.

On February 5th and 6th, Spirecut invited British surgeons to watch live surgeries involving Spirecut’s surgical technique.

We are pleased to announce the expanded availability of Spirecut Sono-Instruments® for the treatment of trigger finger and carpal tunnel syndrome.

Spirecut Live Surgeries in Brussels: March & April Schedule

This technical report contributes to the ongoing advancements in the treatment of trigger finger stenosing tenosynovitis.

Spirecut is attending the Basel Healthtech Conference 2024

Spirecut will sponsor a training on February 4th in Brussels

Spirecut will attend the Hand Winter Course in Val d’Isère.

Spirecut attended a hands-on training for hand surgeons at IRCAD in Strasbourg, France, on January 12-13 2024.

Spirecut attended AAHS annual meeting in Nassau, Bahamas on January 9-13, 2024.

Spirecut attended Slush 2023 from November 30th to December 1st.

Spirecut attended the British Society for Surgery of the Hand (BSSH) annual meeting in Glasgow.

Spirecut has recently achieved a key milestone by securing the CE mark for Sono-Instruments®.

Spirecut will partner with Sovereign Medical and Prof. Joanne Lord from the University of Southampton

Spirecut & Sovereign Medical kicked off surgeons & radiologists trainings in London and Manchester on October 12th and 13th.

A new minimally invasive procedure developed by Prof. Frédéric Schuind and his start-up Spirecut offers a quicker and less invasive solution. Using the Sono-Instruments®, specialists can operate under local anesthesia without making a surgical incision.

Spirecut attended the 10th HealthTech Investment Forum during Sachs Autumn Life Sciences Week in Basel on September 19th.

Spirecut, a Muttenz-based medtech start-up, is revolutionizing hand surgery with a groundbreaking ultrasound-guided technique spearheaded by CEO Frédéric Schuind. Moving away from traditional incision-based methods, Spirecut’s innovation requires a minor puncture to treat common hand disorders such as trigger finger and carpal tunnel syndrome.”

On Friday, June 23rd, Spirecut hosted a training session at Sitem-insel AG, located in Bern, Switzerland. The session primarily focused on the ultrasound-guided percutaneous surgical treatments of two prevalent hand conditions: trigger fingers and carpal tunnel syndrome. Participants included future Key Opinion Leaders (KOLs).

Spirecut has recently joined the Global Nerve Foundation (GNF) as its first-ever Start-up Partner. GNF is an organization dedicated to the betterment of individuals with nerve-related conditions globally.
This partnership resonates with Spirecut’s mission to enhance patient outcomes through ultrasound guidance. The congruity of our visions makes this collaboration a step forward in the direction of patient care enhancement.

Prof Frédéric Schuind, Spirecut’s founder and CEO, recently participated in the X-Health.show podcast. The discussion centered around the latest breakthroughs in hand surgery, with a particular emphasis on trigger finger and carpal tunnel syndrome treatments.

Spirecut marked its presence at the Federation of European Societies for the Surgery of the Hand (FESSH) conference. Professor Moungondo demonstrated our ultrasound-guided technique for treating trigger finger and carpal tunnel syndrome.

Spirecut’s European patent has been officially approved. This represents a significant milestone for our company as it reinforces our intellectual property portfolio. This development will enable us to expand our solutions across Europe, fostering innovation and enhancing healthcare in the region.

The study involved 30 adult participants, equally divided between the two conditions under investigation. One of the critical aspects of this research was the assessment of safety, gauged by the number of severe peri- and post-operative adverse events.

We recently attended Startup Days (SUD), Switzerland’s premier startup conference, providing insights into our innovative solutions and opportunities for meaningful discussions and partnerships.

Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. We now operate out of “The 5th Floor” co-working space in Muttenz with the help of the “100 fürs Baselbiet” program run by BLKB and with the support of Basel Area Business & Innovation.